Back to Journals » OncoTargets and Therapy » Volume 12

Long non-coding RNA NAP1L6 promotes tumor progression and predicts poor prognosis in prostate cancer by targeting Inhibin-β A [Corrigendum]

Authors Zheng Y, Gao Y, Li X, Si S , Xu H, Qi F , Wang J, Cheng G, Hua L , Yang H

Received 18 June 2019

Accepted for publication 18 June 2019

Published 15 August 2019 Volume 2019:12 Pages 6563—6564

DOI https://doi.org/10.2147/OTT.S219868



Zheng Y, Gao Y, Li X, et al. Onco Targets Ther. 2018;11:4965–4977.


On page 4972, the authors found an error in which the images for Figure 4A PC3 Blank and Figure 4B 22RV1 Blank were mistakenly duplicated. Upon realising the error, the authors repeated the knockdown experiment described in Figure 4 and were able to show results consistent with those described in the original article. The authors provided a description of the experiment procedure used for the relative colony counts and the raw data from both the original and repeated experiments used to generate the results shown in Figure 4A and Figure 4B. See revised Figure 4 below.
The authors and the editor have confirmed that the correction of the images has no significant impact on the conclusions of the study.

Read the original article

Creative Commons License © 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.